When.com Web Search

  1. Ads

    related to: pulmonary fibrosis treatment natural

Search results

  1. Results From The WOW.Com Content Network
  2. Pulmonary fibrosis - Wikipedia

    en.wikipedia.org/wiki/Pulmonary_fibrosis

    Pulmonary fibrosis. Pulmonary fibrosis is a condition in which the lungs become scarred over time. [1] Symptoms include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. [1] Complications may include pulmonary hypertension, respiratory failure, pneumothorax, and lung cancer. [2]

  3. Idiopathic pulmonary fibrosis - Wikipedia

    en.wikipedia.org/wiki/Idiopathic_pulmonary_fibrosis

    12 per 100,000 people per year [4] Idiopathic pulmonary fibrosis (IPF) synonymous with cryptogenic fibrosing alveolitis[5] is a rare, progressive illness of the respiratory system, characterized by the thickening and stiffening of lung tissue, associated with the formation of scar tissue.

  4. Interstitial lung disease - Wikipedia

    en.wikipedia.org/wiki/Interstitial_lung_disease

    Interstitial lung disease. Interstitial lung disease (ILD), or diffuse parenchymal lung disease (DPLD), [3] is a group of respiratory diseases affecting the interstitium (the tissue) and space around the alveoli (air sacs) of the lungs. [4] It concerns alveolar epithelium, pulmonary capillary endothelium, basement membrane, and perivascular and ...

  5. Usual interstitial pneumonia - Wikipedia

    en.wikipedia.org/wiki/Usual_interstitial_pneumonia

    Specialty. Respirology. Usual interstitial pneumonia (UIP) is a form of lung disease characterized by progressive scarring of both lungs. [1] The scarring (pulmonary fibrosis) involves the pulmonary interstitium (the supporting framework of the lung). UIP is thus classified as a form of interstitial lung disease.

  6. Theophylline - Wikipedia

    en.wikipedia.org/wiki/Theophylline

    Theophylline. Theophylline, also known as 1,3-dimethylxanthine, is a drug that inhibits phosphodiesterase and blocks adenosine receptors. [1] It is used to treat chronic obstructive pulmonary disease (COPD) and asthma. [2] Its pharmacology is similar to other methylxanthine drugs (e.g., theobromine and caffeine). [1]

  7. Pirfenidone - Wikipedia

    en.wikipedia.org/wiki/Pirfenidone

    In the European Union, pirfenidone is indicated for the treatment of mild-to-moderate idiopathic pulmonary fibrosis. It was approved by the European Medicines Agency in 2011. [8][6] In October 2008, it was approved for use in Japan, in India in 2010, and in China in 2011 (commercial launch in 2014).